Terms: = Pancreatic cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2 AND Prognosis
3 results:
1. Prognostic impact of splenic vessel involvement and tumor size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study.
Gantois D; Guilbaud T; Scemama U; Girard E; Picaud O; Lefevre M; Elgani M; Hamidou Z; Moutardier V; Balandraud P; Chirica M; Barbier L; Fuks D; Birnbaum DJ
Langenbecks Arch Surg; 2022 Feb; 407(1):153-165. PubMed ID: 34373941
[TBL] [Abstract] [Full Text] [Related]
2. Gene coexpression network approach to develop an immune prognostic model for pancreatic adenocarcinoma.
Gu X; Zhang Q; Wu X; Fan Y; Qian J
World J Surg Oncol; 2021 Apr; 19(1):112. PubMed ID: 33845841
[TBL] [Abstract] [Full Text] [Related]
3. A study of multinucleated giant cells in esophageal cancer.
Wang H; Zhou J; Li J; Geng Y; Meng P; Ma C; Zhu Z; Zhang W; Hong L; Quan Y; Wei J; Huang Q; Zhou Y; Su Z; Zhu X; Chen C; Chen S; Gu J
Clin Immunol; 2021 Jan; 222():108600. PubMed ID: 33197619
[TBL] [Abstract] [Full Text] [Related]
